| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $8.1M | $3.4M | $349.0K |
| YoY Revenue Growth % | +136.1% | +887.1% | — |
| Gross Profit | $4.6M | $2.3M | — |
| Gross Margin % | 56.0% | 66.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$7.5M | -$5.0M | -$4.6M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$6.0M | -$11.8M | -$4.6M |
| EBITDA (Normalized) | -$7.2M | -$4.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$5.2M | -$4.9M | -$5.0M |
| Capital Expenditures (CapEx) | $469.0K | $502.0K | — |
| Free Cash Flow (FCF) | -$5.6M | -$5.4M | -$5.0M |
| FCF Margin % | -69.3% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $1.3M | $7.7M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $926.0K | -$5.2M | — |